Navigation Links
Georgetown leads major effort to combat disparities in DC stroke care
Date:10/24/2007

Washington, D.C.More than three quarters of adults living in the District of Columbia have at least one risk factor for stroke, but those who are poor do not receive the same level of care as their wealthier counterparts. In an effort to address these disparities in stroke prevention, diagnosis and treatment in D.C., the NIH's National Institute of Neurological Disorders and Stroke (NINDS) has awarded Georgetown University Medical Center a $10 million cooperative research grant. Chelsea Kidwell, MD, associate professor of neurology at Georgetown, is the principal investigator for the grant, which will involve physicians and scientists from twenty other institutions, including GUMCs clinical partner, Georgetown University Hospital, owned by MedStar Health.

We know that the type of stroke care people get in the United States depends at least in part on their race and socioeconomic status, said Kidwell, who directs both the Georgetown Stroke Center and the Washington Hospital Center Stroke Center. What better place to attempt to reduce these disparities than in the nations capital, where so many patients are coming from medically underserved communities"

Kidwell will oversee three research projects addressing key areas of disparities in stroke care in Washington, D.C. hospitals:

  • Project ASPIRE (Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities) will investigate whether a multi-level intervention can significantly increase the number of ischemic stroke patients appropriately treated with intravenous tissue plasminogen activator (tPA) (clot-busting medication) in D.C. hospitals. If administered within a certain time window, tPA is highly effective at dissolving the blood clots that cause strokes and improving clinical outcomes, said Kidwell, but it is typically delivered to less than 3 percent of patients. Kidwell wants to study the barriers to utilizing this treatment in District hospitals. Amie Hsia
    '/>"/>

Contact: Becky Wexler
rjw43@georgetown.edu
202-687-5100
Georgetown University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Georgetown University Heads Alternative Tobacco Project
2. Drinking arsenic water leads to cancer
3. Doctor Pleads Not Guilty
4. Coronary stent leads to complications
5. Starving leads to obesity
6. Drug abuse leads to long standing changes in the brain
7. Deprived sleep leads to ageing
8. Tobacco chewing leads to dental caries
9. Tongue piercing leads to bacterial infection
10. Cathine leads to mental health disorder
11. Space research leads to needle-free blood tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 01, 2015 EBSCO Health , ... introduced DynaMed Plus™ , a cross-platform evidence-based clinical ... It provides clinicians with the ideal blend of evidence ... paths. , DynaMed Plus is a significant enhancement ... the most frequently updated evidence-based content. DynaMed Plus content ...
(Date:6/1/2015)... June 01, 2015 KC and Monica ... $88,000 of the best superfood products in ... floods in Texas. , "Monica and I are ... News in distributing Living Fuel Super Meals - SuperBerry®, ... millennial floods in Texas," KC Craichy said. "We have ...
(Date:6/1/2015)... Atlanta, GA (PRWEB) June 01, 2015 ... leading publisher of clinical journals in the areas of ... pleased to announce that it has expanded upon its ... newest journal, Hospital Medicine Practice, in a mobile ... smartphones and tablets. , “We are very excited ...
(Date:6/1/2015)... The session, entitled “Building the Blueprint ... president of Elektrobit Automotive Americas, senior representatives from ... will be moderated by Andy Gryc of CX3 Marketing. ... complexity of in-vehicle software in connected vehicles and autonomous ... how the wider ecosystem can fit into new vehicle ...
(Date:6/1/2015)... 2015 Strategic Radiology (SR) announced today ... joined forces with the SR coalition of progressive, independent ... alignment, RRG will now have access to collective resources ... clinical quality, and deployment of subspecialized radiology services. With ... member and affiliate US based radiology group practices. ...
Breaking Medicine News(10 mins):Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 4
... (NYSE: WST ) today announced that Donald E. ... Federici, Chief,Financial Officer, will be presenting at the 2008 ... 11, 2008 in New York City., A copy ... the,investor link of the Company,s website at http://www.westpharma.com ...
... BIOSAFE Laboratories, Inc.,the developer of the BIOSAFE ... have announced the availability of a limited,number of ... identify diabetic and,pre-diabetic children and adolescents. The BIOSAFE ... an immediate fasting glucose reading and,a mail-in laboratory ...
... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ... that it closed its previously announced initial,public offering ... that the,underwriters of the offering have exercised their ... stock from the selling,stockholders at the public offering ...
... (OTC,Bulletin Board: SNKTY), a Life Sciences company engaged ... of healthy aging, today announced,the debut of Pyratine-6(TM) ... of Dermatology in San Antonio, Texas., Pyratine-6(TM), ... to be effective in correcting visible signs of ...
... EnterpriseIQ Supports Device Manufacturer,s Continued Growth and Compliance, ... a leader in the,design and development of Enterprise ... II Medical Manufacturing for its comprehensive ERP,software, EnterpriseIQ. ... medical,device manufacturing industry, so does the level of ...
... Center had sleeplessness, other problems, study shows , , TUESDAY, ... the World Trade Center terrorist attacks boosted behavioral problems ... researchers at the Mount Sinai School of Medicine in ... years of age who lived in or attended preschool ...
Cached Medicine News:Health News:West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 2Health News:BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessment Kits to U.S. School Children 2Health News:IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option 2Health News:Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology 2Health News:Phase II Medical Manufacturing Selects IQMS for ERP Solution 2Health News:Phase II Medical Manufacturing Selects IQMS for ERP Solution 3Health News:9/11 Exposure Linked to Behavior Trouble in Kids 2
(Date:6/1/2015)... , June 1, 2015 CEFALY Technology ... nerve stimulation device specifically authorized for use prior to ... from a new PET trial showing that the Cefaly ... the brain in migraine patients, namely the orbitofrontal cortex ... (PET) scan, which is an imaging test of the brain, used a ...
(Date:6/1/2015)... 2015 NSHOA Cancer Center and Heron ... positive, top-line results from its recently completed Phase ... safety of the Company,s 5-HT 3 receptor ... extended release) as part of a three-drug regimen ... receptor antagonist fosaprepitant and the IV corticosteroid dexamethasone ...
(Date:6/1/2015)... YORK , June 1, 2015   ... of Open, Transparent and Connected financial marketplaces for ... Incorporated, a San Diego -based ... traded on OTCQB®, America,s only public venture market ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ...
Breaking Medicine Technology:New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2New cancer therapy study results - MAGIC Trial 2OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... SAN DIEGO, Aug. 16, 2011 Optimer Pharmaceuticals, Inc. ... subgroup analysis of patients receiving concomitant systemic antibiotics in ... DIFICID™ (fidaxomicin) tablets in the treatment of adult patients ... online in the September 1 issue of Clinical ...
... 16, 2011 CVS/pharmacy announced today that all ... Compliance Corp.,s Environmental Return System, which provides customers ... unused, expired or unwanted drugs using affordable medication ... The postage-paid envelopes cost $3.99 and allow customers ...
Cached Medicine Technology:Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 2Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 3Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 4Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 5Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 6CVS/pharmacy Offers Customers Safe Disposal Program for Medications 2CVS/pharmacy Offers Customers Safe Disposal Program for Medications 3
... with 3 charging wells. Available In 4 ... and Cinnamon. Spring balanced refractor and slit ... construction for lifelong quality. Sealed hydraulic system ... movement. Chair back reclines manually to fully ...
... the patented HydroKeratome corneal cutting device for ... industry experts believe it will replace the ... used in the LASIK refractive procedure. In ... has demonstrated that its proprietary technology is ...
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Coaxial Ophthalmoscope Set with Convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Medicine Products: